4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-024558
CEO and Chairman sold 49,540 shares at an average $27.99 ($1,386,524)
- CEO and Chairman sold 500 shares at $27.62 ($13,810)
- CEO and Chairman acquired 50,040 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS CHAD M CEO and Chairman | 2020-04-13 | Option exercise | +5,560 | $0.33 | $1,835 | 1,883,740 | D |
| ROBINS CHAD M CEO and Chairman | 2020-04-13 | Sale | −1,500 | $24.83 | $37,245 | 1,882,240 | D |
| ROBINS CHAD M CEO and Chairman | 2020-04-13 | Sale | −900 | $25.62 | $23,058 | 1,881,340 | D |
| ROBINS CHAD M CEO and Chairman | 2020-04-13 | Sale | −3,160 | $26.74 | $84,498 | 1,878,180 | D |
| ROBINS CHAD M CEO and Chairman | 2020-04-14 | Option exercise | +33,360 | $0.33 | $11,009 | 1,911,540 | D |
| ROBINS CHAD M CEO and Chairman | 2020-04-14 | Sale | −33,360 | $28.20 | $940,752 | 1,878,180 | D |
| ROBINS CHAD M CEO and Chairman | 2020-04-15 | Option exercise | +11,120 | $0.33 | $3,670 | 1,889,300 | D |
| ROBINS CHAD M CEO and Chairman | 2020-04-15 | Sale | +500 | $27.62 | $13,810 | 1,888,800 | D |
| ROBINS CHAD M CEO and Chairman | 2020-04-15 | Sale | −10,620 | $28.34 | $300,971 | 1,878,180 | D |
| Derivatives | |||||||
| ROBINS CHAD M CEO and Chairman | 2020-04-13 | Option exercise · Stock Option (Right to Buy) | −5,560 | 691,040 | D | ||
| ROBINS CHAD M CEO and Chairman | 2020-04-14 | Option exercise · Stock Option (Right to Buy) | −33,360 | 657,680 | D | ||
| ROBINS CHAD M CEO and Chairman | 2020-04-15 | Option exercise · Stock Option (Right to Buy) | −11,120 | 646,560 | D | ||
| Open-market sales · 50,040 sh · avg $27.98 · $1,400,334 | |||||||
Loading xslF345X03/doc4.xml…